Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-103120
Filing Date
2025-08-05
Accepted
2025-08-05 16:31:13
Documents
76
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q adpt-20250630.htm   iXBRL 10-Q 3145114
2 EX-10.10 adpt-ex10_10.htm EX-10.10 34299
3 EX-31.1 adpt-ex31_1.htm EX-31.1 19023
4 EX-31.2 adpt-ex31_2.htm EX-31.2 19017
5 EX-32.1 adpt-ex32_1.htm EX-32.1 11727
6 EX-32.2 adpt-ex32_2.htm EX-32.2 13120
  Complete submission text file 0000950170-25-103120.txt   11619481

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT adpt-20250630.xsd EX-101.SCH 1188553
79 EXTRACTED XBRL INSTANCE DOCUMENT adpt-20250630_htm.xml XML 2489873
Mailing Address 1165 EASTLAKE AVE E SEATTLE WA 98109
Business Address 1165 EASTLAKE AVE E SEATTLE WA 98109 206-659-0067
Adaptive Biotechnologies Corp (Filer) CIK: 0001478320 (see all company filings)

EIN.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38957 | Film No.: 251185474
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)